[FLT3突变的急性髓性白血病的发病和治疗]
1Department of Hematology and Oncology, Nagoya University Graduate School of Medicine.
[Rinsho ketsueki] The Japanese journal of clinical hematology
|October 2, 2024
概括
在急性髓性白血病 (AML) 中,FLT3突变很常见. FLT3 抑制剂改善预后,新组合疗法获得批准,为更好的患者结果提供希望.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 类似FMS的铁酶3 (FLT3) 突变在成年急性髓性白血病 (AML) 中很普遍,影响大约30%的患者.
- 这种FLT3内部协同重复 (ITD) 突变是AML的显著不良预后因素.
- 对于年轻的AML患者在第一次缓解中,常常建议进行异构造血细胞移植.
研究的目的:
- 审查FLT3突变在AML预后和治疗中的作用.
- 突出FLT3抑制剂对患者结局的影响.
- 讨论FLT3向治疗和响应评估的不断变化的格局.
主要方法:
- 对AML中FLT3突变的当前文献的综述.
- 对FLT3抑制剂的临床试验数据的分析.
- 讨论FLT3突变的预后和治疗影响.
主要成果:
- 在FLT3突变阳性AML中,FLT3抑制剂已证明改善了预后.
- 现在,日本已批准使用quizartinib和化疗的联合治疗,用于未经治疗的FLT3-ITD阳性AML.
- 针对FLT3突变的可测量/最小残留疾病评估是评估反应的宝贵工具.
结论:
- 在AML中,FLT3突变是关键的预后标志物和治疗点.
- 耐药性突变的出现需要对新型治疗策略的持续研究.
- FLT3抑制剂对改善FLT3突变阳性AML的临床结果具有显著的希望.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


